InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,710.17
(
-0.28%
)
Post# of 251706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119567
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: apljack post# 220641

Monday, 03/16/2020 10:01:03 AM

Monday, March 16, 2020 10:01:03 AM

Post# of 251706
ACRX acquires TTPH in all-stock “takeunder” worth $0.65/sh—a 55% discount based on Friday’s closing prices of both stocks—excluding a tiered CVR based on sales milestones for Xerava:

https://www.businesswire.com/news/home/20200316005257/en/Tetraphase-Pharmaceuticals-AcelRx-Pharmaceuticals-Enter-Definitive-Merger

The nominal deal value is $14.4M, excluding the CVR.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up